Aids In India

Samira Guennif ()

Working Papers from eSocialSciences

Abstract: This paper revolves around the Public health related aspects of industrial and intellectual property rights policies in a developing country with respect to Aids in India. It also focusses on its preventive measures, status of the epidemic with referance to the Indian Specificities, measures of Public health, availability and knowledge of condoms, NACO's effort to spread awareness and the ARV production in India with main players as in Cipla and Ranbaxy. [CSH OP NO 8]

Keywords: NACO; HIV; Asia; Northern multinational companies; anti-AIDS treatments; anti-retroviral drugs; Glaxo-Smith-Kline; Bristol-Myers Squibb; Boerhinger- Ingelheim; National AIDS Committee; National AIDS Control Program; sexually transmitted diseases; antenatal clinics; World Bank Model; epidemic; high-risk sexual behaviour; prostitution; public awareness; prevention; blood collection system; NACO objective; ARV; Ranbaxy; Cipla; condoms (search for similar items in EconPapers)
Date: 2009-05
New Economics Papers: this item is included in nep-cwa
Note: Institutional Papers
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (8)

Downloads: (external link)
http://www.esocialsciences.org/Download/repecDownl ... &AId=1974&fref=repec

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ess:wpaper:id:1974

Access Statistics for this paper

More papers in Working Papers from eSocialSciences
Bibliographic data for series maintained by Padma Prakash ().